Cancer Research Career Enhancement and Related Activities With education as the fourth pillar of its overall mission to End Cancer, The University of Texas MD Anderson Cancer Center is an accredited, degree-granting institution with numerous efforts in education, training, and career development across the spectrum of cancer research and translation, the science of cancer prevention, and clinical practice. More than 1,700 faculty and 7,000 annually appointed trainees?from high school through research postdoctoral fellows and clinical residents, as well as a community of lifelong learners among our research and administrative staff?take part in a wide array of offerings sponsored by multiple educational stakeholders from across the institution. Our long-term objective is to establish MD Anderson as a model for education and training in cancer research for a diverse, multidisciplinary research workforce through dissemination of best practices and organization of innovative, evidence-based curricula designed for 21st- century team-based science and clinical practice. Overall, the uniquely broad and rich environment for clinical and research education and professional development at MD Anderson demands easy access to high-quality resources for its learners, as individuals and as groups; for instructors to develop useful and effective activities in synergy; and for support and evaluation of such programs. With this in mind, our 5-year goals include multiple innovative efforts across all CCSG programs in 4 emphasis areas: 1) recruitment coordinated among stakeholders with new approaches that emphasize inclusiveness of underrepresented research trainees and those with disabilities; 2) facilitating access to research education via improved alignment and increased impact; 3) support applications centralized for access by all programs; and 4) program evaluation services tailored for support and improvement of current and developing efforts to improve mentorship and career development. To achieve our long-term objectives for the MD Anderson Cancer Research Career Enhancement and Related Activities (CRCE), our continuous efforts and coordinating role across the institution in education and training are described by these overall aims:
Aim 1 : To recruit, train, and promote a demographically diverse pool of research scientists who span all stages of training and faculty appointment using multiple rigorous strategies to reach broad audiences;
Aim 2 : To provide innovative and evidence-based educational and professional development opportunities in a nurturing culture of shared learning that is attuned to the needs of trainees and faculty mentors;
and Aim 3 : To serve as a coordination and support hub for innovation in education/training, sharing best practices, monitoring research training needs, and program evaluation for MD Anderson researchers, including the community of training programs at MD Anderson.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-43S1
Application #
9997865
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Assi, Rita; Garcia-Manero, Guillermo; Ravandi, Farhad et al. (2018) Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer 124:4192-4201
Alhuraiji, Ahmad; Kantarjian, Hagop; Boddu, Prajwal et al. (2018) Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors. Am J Hematol 93:84-90
Luo, Yangkun; Xu, Yujin; Liao, Zhongxing et al. (2018) Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis? Acta Oncol :1-7
Zhao, Na; Cao, Jin; Xu, Longyong et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128:1283-1299
Liu, Yihua; Weber, Zachary; San Lucas, F Anthony et al. (2018) Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecol Oncol 151:243-249
Joint Head and Neck Radiotherapy-MRI Development Cooperative (2018) Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008
Jensen, Garrett; Tao, Randa; Eng, Cathy et al. (2018) Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 3:595-600
Staffas, Anna; Burgos da Silva, Marina; Slingerland, Ann E et al. (2018) Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice. Cell Host Microbe 23:447-457.e4
Boddu, Prajwal; Borthakur, Gautam; Koneru, Mythili et al. (2018) Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Front Oncol 8:369
Takahashi, Nobuaki; Chen, Hsing-Yu; Harris, Isaac S et al. (2018) Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. Cancer Cell 33:985-1003.e7

Showing the most recent 10 out of 12418 publications